The complement cascade is a complex inflammatory process that can mediate diverse functions, from targeting cells and cellular components for phagocytosis to membrane attack complex-mediated cell death. In this context, there are 20 or more individual proteins that participate in the complement cascade. Immunoreactivity for a wide variety of complement proteins, e.g., C1q and the terminal membrane attack complex (MAC or C5b-9), has been reported in association with both β-amyloid plaques and neurofibrillary tangles (NFT) in AD brain. Previous work by several laboratories, including that of Joseph Rogers and Andrea Tenner, has demonstrated that β-amyloid 1-42 can activate complement and bind complement proteins including the C1q A chain. In a newer study, Rogers et al. report that a purified fraction of isolated NFTs can also activate a complement response (Abstract 502.10). Recombinant tau also activated terminal complement in a dose-dependent manner nearly as efficiently as synthetic Aβ 1-42. Further, a fraction of isolated tau that formed fibrils, as compared to soluble recombinant tau, activated complement even more strongly. These data may suggest that both β-amyloid plaques and NTFs could serve as chronic mediators of an inflammatory response in the AD brain.-Aileen Anderson.


Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

Comments on Primary Papers for this Article

No Available Comments on Primary Papers for this Article


No Available References

Further Reading

No Available Further Reading